Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents

被引:162
作者
Poon, B
Grovit-Ferbas, K
Stewart, SA
Chen, ISY [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol & Med, AIDS Inst, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Med, AIDS Inst, Los Angeles, CA 90095 USA
[4] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90095 USA
关键词
D O I
10.1126/science.281.5374.266
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Expression of human immunodeficiency virus-type 1 (HIV-1) Vpr after productive infection of T cells induces cell cycle arrest in the G(2) phase of the cell cycle. In the absence of de novo expression, HIV-1 Vpr packaged into virions still induced cell cycle arrest. Naturally noninfectious virus or virus rendered defective for infection by reverse transcriptase or protease inhibitors were capable of inducing Vpr-mediated cell cycle arrest. These results suggest a model whereby both infectious and noninfectious virions in vivo, such as those surrounding follicular dendritic cells, participate in immune suppression.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 50 条
  • [1] [Anonymous], 1989, SYNTHETIC OLIGONUCLE
  • [2] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [3] HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B
    Ayyavoo, V
    Mahboubi, A
    Mahalingam, S
    Ramalingam, R
    Kudchodkar, S
    Williams, WV
    Green, DR
    Weiner, DB
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1117 - 1123
  • [4] DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE
    BALLIET, JW
    KOLSON, DL
    EIGER, G
    KIM, FM
    MCGANN, KA
    SRINIVASAN, A
    COLLMAN, R
    [J]. VIROLOGY, 1994, 200 (02) : 623 - 631
  • [5] BALOTTO CP, 1993, J EXP MED, V176, P1099
  • [6] CAMERINI D, 1994, SCIENCE, V264, P1160, DOI 10.1126/science.7909961
  • [7] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection
    Chun, TW
    Carruth, L
    Finzi, D
    Shen, XF
    DiGiuseppe, JA
    Taylor, H
    Hermankova, M
    Chadwick, K
    Margolick, J
    Quinn, TC
    Kuo, YH
    Brookmeyer, R
    Zeiger, MA
    BarditchCrovo, P
    Siliciano, RF
    [J]. NATURE, 1997, 387 (6629) : 183 - 188
  • [8] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
    Chun, TW
    Stuyver, L
    Mizell, SB
    Ehler, LA
    Mican, JAM
    Baseler, M
    Lloyd, AL
    Nowak, MA
    Fauci, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197
  • [9] COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN
    COHEN, EA
    DEHNI, G
    SODROSKI, JG
    HASELTINE, WA
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (06) : 3097 - 3099